北京大学学报(医学版) ›› 2020, Vol. 52 ›› Issue (4): 715-718. doi: 10.19723/j.issn.1671-167X.2020.04.023

• 论著 • 上一篇    下一篇

《严重过敏反应急救指南》临床问题与结局指标的收集和确定

郑航慈1,2,3,李晓桐1,2,3,门鹏1,2,马翔1,2,王强4,陈耀龙5,翟所迪1,3,*()   

  1. 1. 北京大学第三医院药剂科,北京 100191
    2. 北京大学药学院药事管理与临床药学系,北京 100191
    3. 北京大学医学部药物评价中心,北京 100191
    4. 国家卫生健康委员会医疗标准处,北京 100044
    5. 兰州大学循证医学中心,兰州 730000
  • 收稿日期:2018-06-27 出版日期:2020-08-18 发布日期:2020-08-06
  • 通讯作者: 翟所迪 E-mail:zhaisuodi@163.com

Selecting and defining the clinical questions and outcomes of Guideline for the Emergency Treatment of Anaphylaxis

Hang-ci ZHENG1,2,3,Xiao-tong LI1,2,3,Peng MEN1,2,Xiang MA1,2,Qiang WANG4,Yao-long CHEN5,Suo-di ZHAI1,3,*()   

  1. 1. Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China
    2. Department of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical Sciences, Beijing 100191, China
    3. Institute for drug evaluation, Peking University Health Science Center, Beijing 100191, China
    4. Department of Standards, National Health Commission, Beijing 100044, China
    5. Evidence-based Medicine Center, Lanzhou University, Lanzhou 730000, China
  • Received:2018-06-27 Online:2020-08-18 Published:2020-08-06
  • Contact: Suo-di ZHAI E-mail:zhaisuodi@163.com

摘要:

目的: 确定纳入《严重过敏反应急救指南》的临床问题与结局指标。方法: 由指南指导委员会7位临床医学、药学及护理学专家参考国际指南指导项目组起草、修订拟纳入指南的临床问题与结局指标初稿。临床问题分为背景问题与前景问题,其中背景问题在专家共识组共22位临床专家修订后直接纳入指南范围,前景问题与结局指标将通过三轮德尔菲法对共识组临床专家咨询形成终稿。研究在方法学家全程监督下完成,并通过分析积极系数、变异系数与分值频率等指标进行质量控制。结果: 问题征集初拟共纳入34个前景问题、6个背景问题及6个结局指标,背景问题经专家组修订后直接纳入指南。使用德尔菲法(Delphi method)对前景问题与结局指标的重要程度进行分级后,最终确定28个关键前景问题及6个结局指标纳入指南范围。其中,4个结局指标为关键性结局,其余2个为重要结局,纳入的28个关键前景问题分为严重过敏反应的诊断、救治准备、救治措施及救治后的管理四个部分,另有5个重要问题和1个次要问题此次未纳入指南,供指南修订或更新时参考或讨论。研究中专家响应的积极程度高,积极系数为100%;前景问题的共识程度高,4分及以上的问卷频率均≥0.75;结局指标中,病死率及疾病严重程度的共识程度高,变异系数≤15%。结论: 在全面严谨的信息收集基础上,以德尔菲法的方式确定了需要纳入《严重过敏反应急救指南》的临床问题与结局指标为该指南的后续制定工作奠定了基础。

关键词: 过敏反应, 指南, 德尔菲法, 临床问题, 结局指标

Abstract:

Objective: To select and define the clinical questions and outcomes of Guideline for the Emergency Treatment of Anaphylaxis. Methods: A draft including clinical questions, which could be divided into foreground questions and background questions, and outcomes was drawn and revised by the secretary group for the guideline referring to the present guidelines with the guidance of a panel consisting of 7 experienced clinical medicine, pharmacy and nursing experts. Foreground questions and outcomes of the draft were voted into a final version after three rounds of counsels of 22 experienced medicine, pharmacy and nursing clinical experts using Delphi method including 3 rounds of inquiry. And the background questions were directly included in the guideline after the 22 experts' thorough revising. The research was carried out under the supervision of method ologists. Active coefficient, coefficient of variation and the frequencies of each score were calculated for quality control. Results: The draft of 34 foreground questions, 6 background questions and 6 outcomes was finally drawn up after thorough selecting and consulting. The 6 background questions revised by the clinical experts were all included. After three rounds of Delphi method, 28 pivotal clinical questions covering the diagnosis, preparation for the treatment, treatment and administration after the treatment, and 6 outcomes were defined and included for the guideline. The rest of the foreground questions, 4 of which were recognized as essential and 2 as important, were excluded from the guideline and left for further revising or updating. As for the outcomes, 4 of them were recognized as critical and the rest as important. The experts contributing to the research were active as the active coefficient reached 100%, and the degree of consensus was fine as the frequencies of the feedback scoring equal to or greater than 4 for all the 28 foreground questions included were greater than 75% and the result was settled in the first round. And 2 outcomes, fatality rate and severity, reached a higher degree of consensus with coefficient of variation less than 15%. Conclusion: After thorough and rigorous selecting, the clinical questions and outcomes to be included in the Guideline for the Emergency Treatment of Anaphylaxis were finally selected and defined via Delphi method, guiding the future development of the guidelines.

Key words: Anaphylaxis, Guidelines, Delphi method, Clinical question, Outcome

中图分类号: 

  • R499
1 Powell C . The Delphi technique: myths and realities[J]. J Adv Nurs, 2010, 41 (4): 376- 382.
2 World Health Organization. WHO handbook for guideline development[M]. 2nd ed. Geneva: World Health Organization, 2014.
3 王少娜, 董瑞, 谢晖, 等. 德尔菲法及其构建指标体系的应用进展[J]. 蚌埠医学院学报, 2016, 41 (5): 695- 698.
4 Simons FE , Ardusso LR , Bilò MB , et al. 2012 Update: World allergy organization guidelines for the assessment and management of anaphylaxis[J]. Curr Opin Allergy Clin Immunol, 2012, 12 (4): 389- 399.
doi: 10.1097/ACI.0b013e328355b7e4
5 National Clinical Guideline Centre (UK). NICE Clinical Guidelines, No. 183. Drug allergy: diagnosis and management of drug allergy in adults, children and young people[R/OL]. London: National Institute for Health and Care Excellence (UK), 2014. https://www.ncbi.nlm.nih.gov/books/NBK248066/.
6 Muraro A , Roberts G , Worm M , et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology[J]. Allergy, 2014, 69 (8): 1026- 1045.
doi: 10.1111/all.12437
7 Soar J , Pumphrey R , Cant A , et al. Emergency treatment of anaphylactic reactions: guidelines for healthcare providers[J]. Resuscitation, 2008, 77 (2): 157- 169.
doi: 10.1016/j.resuscitation.2008.02.001
8 Institute of Medicine. Clinical practice guidelines we can trust[M]. Washington D.C., US: National Academies Press, 2011.
9 Shaneyfelt T . In guidelines we cannot trust: Comment on "Failure of clinical practice guidelines to meet Institute of Medicine Stan-dards"[J]. Arch Intern Med, 2012, 172 (21): 1633- 1634.
doi: 10.1001/2013.jamainternmed.335
10 Schünemann HJ , Wiercioch W , Etxeandia I , et al. Guidelines 2.0: Systematic development of a comprehensive checklist for a successful guideline enterprise[J]. CMAJ, 2014, 186 (3): E123- E142.
doi: 10.1503/cmaj.131237
[1] 高乐,于树青,杨继春,马峻岭,詹思延,孙凤. 全球结直肠癌筛查指南的质量评价[J]. 北京大学学报(医学版), 2019, 51(3): 548-555.
[2] 邱敏,宗亚楠,卢剑,马潞林,郑清,郭向阳. 罗库溴铵致过敏性休克1例[J]. 北京大学学报(医学版), 2015, 47(5): 885-887.
[3] 张永珍, 高炜. 稳定性冠心病诊治策略的选择:欧美指南给我们的提示[J]. 北京大学学报(医学版), 2014, 46(6): 832-835.
[4] 张凯, 徐奔, 肖云翔, 商学军, 白文俊, 王晓峰, 刘继红, 邓春华. 中国泌尿外科医师慢性骨盆疼痛综合征诊疗模式调查[J]. 北京大学学报(医学版), 2014, 46(4): 578-581.
[5] 薛晓艳, 高占成, 朱继红, 徐钰, 李信. 中国社区获得性肺炎诊断和治疗指南的评价[J]. 北京大学学报(医学版), 2006, 38(3): 276-279.
[6] 景霞, 张其鹏, 国强华, 卢铭, 朱晓华, 石磊, 芮伟, 尚彤. 网上免费医学生物学数据库指南的建立[J]. 北京大学学报(医学版), 2004, 36(3): 322-326.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . 书讯[J]. 北京大学学报(医学版), 2007, 39(3): 225 -328 .
[2] 樊志荣, 卢义侠, 李长龄. 肾病综合征大鼠肾小球血管紧张素Ⅱ受体结合的变化及机制[J]. 北京大学学报(医学版), 2001, 33(6): 565 .
[3] 范蓉, 张成飞, 高岩, 李斌斌, 王晶. 核因子-κB受体活化因子配体和骨保护素在慢性根尖周炎病损组织中的表达[J]. 北京大学学报(医学版), 2008, 40(1): 39 -42 .
[4] 章巍, 王广发, 张红, 牟向东, 金哲. 用内科胸腔镜进行滑石粉胸膜固定术治疗恶性胸腔积液27例临床分析[J]. 北京大学学报(医学版), 2008, 40(6): 600 -602 .
[5] 陈磊, 张豪, 冯海兰, 张凤军. 正常受试者单侧咀嚼运动中的牙合接触模式[J]. 北京大学学报(医学版), 2009, 41(1): 90 -94 .
[6] 黄萍, 刘炯, 夏英杰, 仲燕莹, 陈跃国. 两种准分子激光手术治疗超高度近视的对比研究[J]. 北京大学学报(医学版), 2007, 39(5): 498 -502 .
[7] 马红, 高妍, 杨建梅, 惠岩, 陈澜, 王淑凤. 人血浆瘦素水平与肥胖及血浆胰岛素水平的关系[J]. 北京大学学报(医学版), 2001, 33(6): 559 -561 .
[8] 熊祖应, 黄海长, 李惊子, 王海燕. 活动性肾小球肾炎中过氧化脂质体增殖激活受体γ在肾脏的表达[J]. 北京大学学报(医学版), 2003, 35(5): 499 -502 .
[9] 陈亚红, 姚婉贞, 赵鸣武, 庞永政, 唐朝枢. 哮喘气道重塑中钙调神经磷酸酶与蛋白激酶活性的相互调节[J]. 北京大学学报(医学版), 2005, 37(6): 599 -602 .
[10] 陈世伟, 张立实, 张红敏, 冯晓凡, 彭晓莉. 大豆异黄酮对胰岛素抵抗大鼠胰岛素敏感性及瘦素基因表达的影响[J]. 北京大学学报(医学版), 2006, 38(2): 197 -200 .